Cargando…

New Deferric Amine Compounds Efficiently Chelate Excess Iron to Treat Iron Overload Disorders and to Prevent Ferroptosis

Excess iron accumulation occurs in organs of patients with certain genetic disorders or after repeated transfusions. No physiological mechanism is available to excrete excess iron and iron overload to promote lipid peroxidation to induce ferroptosis, thus iron chelation becomes critical for preventi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Wenya, Xiao, Yuanjing, Zhao, Chuanfang, Zhang, Zhanming, Liu, Wei, Ma, Juan, Ganz, Tomas, Zhang, Junliang, Liu, Sijin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561787/ https://www.ncbi.nlm.nih.gov/pubmed/36031399 http://dx.doi.org/10.1002/advs.202202679

Ejemplares similares

Iron Chelators in Treatment of Iron Overload
por: Entezari, Sarina, et al.
Publicado: (2022)

Naringin Chelates Excessive Iron and Prevents the Formation of Amyloid-Beta Plaques in the Hippocampus of Iron-Overloaded Mice
por: Jahanshahi, Mehrdad, et al.
Publicado: (2021)

Comparison Between Hesperidin, Coumarin, and Deferoxamine Iron Chelation and Antioxidant Activity Against Excessive Iron in the Iron Overloaded Mice
por: Aalikhani, Mahdi, et al.
Publicado: (2022)

From Iron Chelation to Overload as a Therapeutic Strategy to Induce Ferroptosis in Leukemic Cells
por: Grignano, Eric, et al.
Publicado: (2020)

A Review on Iron Chelators in Treatment of Iron Overload Syndromes
por: Mobarra, Naser, et al.
Publicado: (2016)

The Role of Macrophage Iron Overload and Ferroptosis in Atherosclerosis
por: Ma, Jiedong, et al.
Publicado: (2022)

Controversies on the Consequences of Iron Overload and Chelation in MDS
por: Vinchi, Francesca, et al.
Publicado: (2020)

Iron Chelation Therapy with Deferasirox in the Management of Iron Overload in Primary Myelofibrosis
por: Elli, Elena Maria, et al.
Publicado: (2014)

Korean Guideline for Iron Chelation Therapy in Transfusion-Induced Iron Overload
por: Jang, Jun Ho, et al.
Publicado: (2013)

Iron chelation effect of curcumin and baicalein on aplastic anemia mouse model with iron overload
por: Dijiong, Wu, et al.
Publicado: (2019)

Management of transfusional iron overload – differential properties and efficacy of iron chelating agents
por: Kwiatkowski, Janet L
Publicado: (2011)

Effect of iron overload and iron-chelating therapy on allogeneic hematopoietic SCT in children
por: Lee, J W, et al.
Publicado: (2009)

Iron Overload and Breast Cancer: Iron Chelation as a Potential Therapeutic Approach
por: Islam, Sufia, et al.
Publicado: (2022)

Does Pathological Iron Overload Impair the Function of Human Lungs?
por: Ganz, Tomas
Publicado: (2017)

Iron Overload Protects from Obesity by Ferroptosis
por: Ma, Wan, et al.
Publicado: (2021)

Overview of guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload
por: Gattermann, Norbert
Publicado: (2008)

Iron chelators or therapeutic modulators of iron overload: Are we anywhere near ideal one?
por: Ghosh, Kanjaksha, et al.
Publicado: (2018)

Erythrocytapheresis in Children and Young Adults with Hemoglobinopathies and Iron Overload in Need of Iron Chelation Therapy
por: van Hattem, Jessica, et al.
Publicado: (2023)

New thiazolidinones reduce iron overload in mouse models of hereditary hemochromatosis and β-thalassemia
por: Liu, Jing, et al.
Publicado: (2019)

Iron Overload and Chelation Therapy in Non-Transfusion Dependent Thalassemia
por: Bou-Fakhredin, Rayan, et al.
Publicado: (2017)

PPARα alleviates iron overload‐induced ferroptosis in mouse liver
por: Xing, Guowei, et al.
Publicado: (2022)

Combined Iron Chelator and Antioxidant Exerted Greater Efficacy on Cardioprotection Than Monotherapy in Iron-Overloaded Rats
por: Wongjaikam, Suwakon, et al.
Publicado: (2016)

Hepcidin gene polymorphisms and iron overload in β-thalassemia major patients refractory to iron chelating therapy
por: Zarghamian, Parinaz, et al.
Publicado: (2020)

High-Altitude Hypoxia Exposure Induces Iron Overload and Ferroptosis in Adipose Tissue
por: Zhang, Yanfei, et al.
Publicado: (2022)

Iron overload causes a mild and transient increase in acute lung injury
por: Zhang, Vida, et al.
Publicado: (2020)

Iron overload and iron chelating agent exposure in anemia-associated outer retinal degeneration: a case report and review of the literature
por: Belmouhand, Mohamed, et al.
Publicado: (2021)

Chelators for Treatment of Iron and Copper Overload: Shift from Low-Molecular-Weight Compounds to Polymers
por: Hruby, Martin, et al.
Publicado: (2021)

Iron Overload, Oxidative Stress, and Ferroptosis in the Failing Heart and Liver
por: Mancardi, Daniele, et al.
Publicado: (2021)

The Impacts of Iron Overload and Ferroptosis on Intestinal Mucosal Homeostasis and Inflammation
por: Huo, Caiyun, et al.
Publicado: (2022)

Iron-Chelating Agent Can Maintain Bone Homeostasis Disrupted by Iron Overload by Upregulating Wnt/Beta-Catenin Signaling
por: Xu, Wei, et al.
Publicado: (2020)

Chelation Therapy with Oral Solution of Deferiprone in Transfusional Iron-Overloaded Children with Hemoglobinopathies
por: Makis, Alexandros, et al.
Publicado: (2013)

Efficacy and safety of deferasirox, an oral iron chelator, in heavily iron-overloaded patients with β-thalassaemia: the ESCALATOR study
por: Taher, Ali, et al.
Publicado: (2009)

Combination Iron Chelation Therapy with Deferiprone and Deferasirox in Iron-Overloaded Patients with Transfusion-Dependent β-Thalassemia Major
por: Karami, Hossein, et al.
Publicado: (2017)

Improvement of chronic hepatitis B by iron chelation therapy in a patient with iron overload: A case report
por: Zou, Dong-Mei, et al.
Publicado: (2017)

Safety and Efficacy of the New Combination Iron Chelation Regimens in Patients with Transfusion-Dependent Thalassemia and Severe Iron Overload
por: Origa, Raffaella, et al.
Publicado: (2022)

The effects of secondary iron overload and iron chelation on a radiation-induced acute myeloid leukemia mouse model
por: Chan, Lap Shu Alan, et al.
Publicado: (2021)

Thymosin β4 Is an Endogenous Iron Chelator and Molecular Switcher of Ferroptosis
por: Lachowicz, Joanna I., et al.
Publicado: (2022)

Erythroferrone exacerbates iron overload and ineffective extramedullary erythropoiesis in a mouse model of β-thalassemia
por: Olivera, Joseph, et al.
Publicado: (2023)

The Impact of Iron Overload and Ferroptosis on Reproductive Disorders in Humans: Implications for Preeclampsia
por: Ng, Shu-Wing, et al.
Publicado: (2019)

Iron Chelation Therapy with Deferasirox Results in Improvement of Liver Enzyme Level in Patients with Iron Overload-Associated Liver Dysfunction
por: Miura, Yasuo, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_2o6tkc9n10i8cbhc9i89fgktek